DSM Nutritional Products Reports Women’s Health Breakthrough

The clinical trial, conducted in collaboration with Creighton University, Omaha, USA, took the form of a pilot, randomized, placebo-controlled, double-blind study in 58 healthy, early postmenopausal women.

12 May 2010 --- Leading nutritional ingredients producer DSM Nutritional Products announces that their geniVida Bone Blend has been shown in a clinical trial to significantly increase bone mineral density by up to 3.4% in post-menopausal women after only 6 months supplementation. This new data was presented at the IOF World Congress on Osteoporosis, Florence, Italy, May 5-8,
2010.

Due to an ageing population, bone loss and the resulting increased risk of bone fracture is a growing problem globally. Approximately a third of postmenopausal women in USA and Europe are affected.

The clinical trial, conducted in collaboration with Creighton University, Omaha, USA, took the form of a pilot, randomized, placebo-controlled, double-blind study in 58 healthy, early postmenopausal women. The geniVida Bone Blend is a patent protected combination of geniVida brand pure genistein, omega-3 fatty acids EPA and DHA, and the vitamins D3 and K1.

William Black, Vice-President of New Nutritional Ingredients at DSM, says: “The new study provides evidence of the significant health benefits offered by a multi-nutrient solution to a multifactorial health issue such as bone mineral density. This new evidence complements previous data showing significant menopause symptom (hot flush) relief for post-menopausal women supplementing with geniVida genistein. geniVida therefore potentially offers solutions for unmet short-term and long-term health needs for mature women”.